Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.4, indicating a new version of the study record history.
    Difference
    0.1%
    Check dated 2026-05-15T15:24:15.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor system/version change for the record history interface.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision entry added: v3.5.2. Previous entry v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:52.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision v3.5.0 has been added and revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:43.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision history shows an addition of revision v3.4.3 and a deletion of revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:36.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Study Status and Recruitment Status were updated to Active, not recruiting, and the Contacts/Locations section was added/updated in the latest version (v43) with the dates 2026-03-03 and 2026-03-04.
    Difference
    0.4%
    Check dated 2026-03-05T00:59:17.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.